TNF and rheumatoid arthritis: The results of a study by Chastek et al. on the comparative efficacy of TNF blockers in RA patients treated with Adalimumab, Etanercept, and Infliximab from January 1, 2006, to 2008 showed that Etanercept had the lowest dose and the patients showed the best response to Infliximab [52].